BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31102628)

  • 1. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
    Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
    Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.
    Chen K; Lee A; Huang HH; Tay KJ; Sim A; Lee LS; Cheng CWS; Ng LG; Ho HSS; Yuen JSP
    Int J Urol; 2019 Apr; 26(4):465-474. PubMed ID: 30818418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative 30-day Mortality Rates for Kidney Cancer Are Dependent on Hospital Surgical Volume: Results from a Norwegian Population-based Study.
    Hjelle KM; Johannesen TB; Beisland C
    Eur Urol Focus; 2017 Apr; 3(2-3):300-307. PubMed ID: 28753795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Partial nephrectomy vs. radical nephrectomy for tumor>7cm].
    Chebbi A; Benoit T; Giwerc A; Roumiguié M; Aublé A; Doumerc N; Soulié M; Pfister C; Beauval JB; Nouhaud FX
    Prog Urol; 2017 Feb; 27(2):80-86. PubMed ID: 28161366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).
    Bertolo R; Autorino R; Simone G; Derweesh I; Garisto JD; Minervini A; Eun D; Perdona S; Porter J; Rha KH; Mottrie A; White WM; Schips L; Yang B; Jacobsohn K; Uzzo RG; Challacombe B; Ferro M; Sulek J; Capitanio U; Anele UA; Tuderti G; Costantini M; Ryan S; Bindayi A; Mari A; Carini M; Keehn A; Quarto G; Liao M; Chang K; Larcher A; De Naeyer G; De Cobelli O; Berardinelli F; Zhang C; Langenstroer P; Kutikov A; Chen D; De Luyk N; Sundaram CP; Montorsi F; Stein RJ; Haber GP; Hampton LJ; Dasgupta P; Gallucci M; Kaouk J; Porpiglia F
    Eur Urol; 2018 Aug; 74(2):226-232. PubMed ID: 29784191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
    Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
    Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
    Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
    Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
    Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.
    Forbes CM; Rendon RA; Finelli A; Kapoor A; Moore RB; Breau RH; Lacombe L; Kawakami J; Drachenberg DE; Pautler SE; Jewett MMA; Saarela O; Liu Z; Tanguay S; Black PC
    Urol Oncol; 2016 Nov; 34(11):486.e17-486.e23. PubMed ID: 27423824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.